Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-03

FDA Approved: CALCIPOTRIENE — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approved a supplemental application for Calcipotriene from Prasco Laboratories, indicating an addition or modification to the drug's existing approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcipotriene (calcipotriene)

Snippet

SUPPL AP for CALCIPOTRIENE (CALCIPOTRIENE)